- Home
- EOG vs GSK Comparison
EOG vs GSK Comparison
Compare EOG & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOG
- GSK
- Stock Information
- Founded
- EOG 1985
- GSK 1715
- Country
- EOG United States
- GSK United Kingdom
- Employees
- EOG N/A
- GSK N/A
- Industry
- EOG Oil & Gas Production
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- EOG Energy
- GSK Health Care
- Exchange
- EOG Nasdaq
- GSK Nasdaq
- Market Cap
- EOG 65.3B
- GSK 77.1B
- IPO Year
- EOG N/A
- GSK N/A
- Fundamental
- Price
- EOG $119.03
- GSK $39.32
- Analyst Decision
- EOG Buy
- GSK Hold
- Analyst Count
- EOG 21
- GSK 2
- Target Price
- EOG $139.89
- GSK N/A
- AVG Volume (30 Days)
- EOG 2.9M
- GSK 4.5M
- Earning Date
- EOG 08-07-2025
- GSK 07-30-2025
- Dividend Yield
- EOG 3.43%
- GSK 4.11%
- EPS Growth
- EOG N/A
- GSK N/A
- EPS
- EOG 10.30
- GSK 1.13
- Revenue
- EOG $22,798,000,000.00
- GSK $43,336,073,439.00
- Revenue This Year
- EOG $1.18
- GSK $5.56
- Revenue Next Year
- EOG $12.91
- GSK $5.08
- P/E Ratio
- EOG $11.55
- GSK $34.73
- Revenue Growth
- EOG N/A
- GSK 0.59
- 52 Week Low
- EOG $102.52
- GSK $31.72
- 52 Week High
- EOG $138.18
- GSK $44.67
- Technical
- Relative Strength Index (RSI)
- EOG 51.02
- GSK 59.10
- Support Level
- EOG $113.36
- GSK $36.75
- Resistance Level
- EOG $119.93
- GSK $39.33
- Average True Range (ATR)
- EOG 2.73
- GSK 0.66
- MACD
- EOG 0.14
- GSK 0.26
- Stochastic Oscillator
- EOG 57.51
- GSK 99.61
About EOG EOG Resources Inc.
EOG Resources is an oil and gas producer with acreage in several US shale plays, primarily in the Permian Basin and the Eagle Ford. At the end of 2024, it reported net proven reserves of 4.7 billion barrels of oil equivalent. Net production averaged roughly 1,062 thousand barrels of oil equivalent per day in 2024 at a ratio of 69% oil and natural gas liquids and 31% natural gas.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.